Fate Therapeutics Inc
FATE
NASDAQ
Biotechnology
$2.57
USD
+0.05 (+1.98%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $293.73M
Volume 2.0M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
FHTX | Foghorn Therapeutics Inc | $370.56M | - | +52.0% | - | |
TLSI | TriSalus Life Sciences Inc | $343.59M | - | +39.6% | - | |
IKT | Inhibikase Therapeutics Inc | $324.80M | - | - | - | |
FATE | Fate Therapeutics Inc | $317.04M | - | -52.6% | - | |
GALT | Galectin Therapeutics Inc | $316.67M | - | - | - | |
AGEN | Agenus Inc | $310.64M | 4.81 | +24.5% | - | |
MYGN | Myriad Genetics Inc | $307.03M | - | -3.2% | - | |
VNDA | Vanda Pharmaceuticals Inc | $304.35M | - | +8.2% | - | |
AVXL | Anavex Life Sciences Corp | $300.34M | - | - | - | |
ZNTL | Zentalis Pharmaceuticals Inc | $298.98M | - | - | - |
Top Peer by Growth
TriSalus Life Sciences Inc
+39.6% YoY Revenue
Best 1-Year Return
Opus Genetics Inc
+238.2% Return